Main > HEMATOLOGY > USA. A. Apixaban; Rivaroxaban Antid

ote

USA. A. Apixaban; Rivaroxaban Antid's subsections
(*) EU Approval Date: 2019. 04.26.
(*) USA Approval Date: 2018. 05.03
Company
Generic Name
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 9
Patent>UpDate: 2018. 05.01
TradeMark EU
TradeMark USA
TradeMark USA Web-Site

USA. A. Apixaban; Rivaroxaban Antid's products
This section has no products